Investing.com - UCB reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that was inline with expectations.
UCB announced earnings per share of €2.05 on revenue of €1.52B. Analysts polled by Investing.com anticipated EPS of €2.90 on revenue of €1.52B.
UCB shares are down 52% from the beginning of the year, still down 32.82% from its 52 week high of €116.05 set on April 14. They are under-performing the STOXX 600 which is down 11.28% from the start of the year.
UCB follows other major Healthcare sector earnings this month
UCB's report follows an earnings beat by Argen-X on Thursday, who reported EPS of €-3.75 on revenue of €83.88M, compared to forecasts EPS of €-4.77 on revenue of €39.04M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar